Maximum quantity allowed is 999
CAS RN: 83919-23-7 | Product Number: M2354
Mometasone Furoate

Purity: >98.0%(HPLC)
- (11β,16α)-9,21-Dichloro-17-[(2-furanylcarbonyl)oxy]-11-hydroxy-16-methylpregna-1,4-diene-3,20-dione
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
200MG |
₹7,300.00
|
2 | 37 |
|
1G |
₹17,800.00
|
3 | 10 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | M2354 |
Purity / Analysis Method ![]() |
>98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__2__7H__3__0Cl__2O__6 = 521.43 |
Physical State (20 deg.C) | Solid |
Storage Temperature ![]() |
Refrigerated (0-10°C) |
Condition to Avoid | Heat Sensitive |
Packaging and Container ![]() |
1G-Glass Bottle with Plastic Insert (View image) |
CAS RN | 83919-23-7 |
Reaxys Registry Number | 4340538 |
PubChem Substance ID | 172088987 |
Merck Index (14) | 6241 |
MDL Number | MFCD00866003 |
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Melting point | 212.0 to 216.0 °C |
Specific rotation [a]20/D | +48.0 to +52.0 deg(C=0.5、MeOH) |
NMR | confirm to structure |
Melting Point | 214 °C(dec.) |
Specific Rotation | 50° (C=0.5,MeOH) |
Pictogram |
![]() |
Signal Word | Warning |
Hazard Statements | H361 : Suspected of damaging fertility or the unborn child. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P405 : Store locked up. |
RTECS# | TU3822000 |
References
- A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate
- In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids
- C. L. Smith, W. Kreutner, Arzneim.-Forsch. 1998, 48, 956.
- The inhibitory effects of topically active glucocorticoids on IL-4, IL-5, and interferon-gamma production by cultured primary CD4+ T cells
- Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis
- Progesterone receptor ligand binding pocket flexibility: crystal structures of norethindrone and mometasone furoate complexes
Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.